Status:
COMPLETED
Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Respiratory Distress Syndrome
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE3
Brief Summary
To determine if surfactant administration at birth in infants at high risk for respiratory distress syndrome (RDS) modified the clinical course of the syndrome.
Detailed Description
BACKGROUND: Respiratory distress syndrome affects more than 40,000 infants annually in the United States. The overall mortality rate exceeds 20 percent and in infants weighing less than 1500 grams at...
Eligibility Criteria
Boy and girl preterm infants 24-29 weeks of gestational age and 500-1400 grams birthweight.
Key Trial Info
Start Date :
January 1 1986
Trial Type :
INTERVENTIONAL
End Date :
June 1 1990
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000570
Start Date
January 1 1986
End Date
June 1 1990
Last Update
December 13 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.